17 February 2021
Visiongain has published a new report on Wound Dressings Market Report 2021-2031: Forecasts by Type (Traditional, Advanced), Wound Type (Traumatic, Surgical, Diabetic Foot, Venous Leg Ulcer & Burns), End User (Hospital, ASCs, Homecare). PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Global Wound Dressings market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031.
The wound is categorised as acute and chronic. Wound healing is a dynamic and complex process which requires uitable environment to promote healing process. With the progress in technology, more than 4000 products have been developed to treat different types of wounds by targeting various aspects of healing process. A wound is defined as a disruption in the continuity of the epithelial lining of the skin or mucosa resulting from physical or thermal damage.
The process of wound dressing has remained traditional until recently when modern science discovered that moisture and proper aeration is imperative for the adequate growth of underlying epidermal or endoderm cells. Researches have revealed that moisture and aeration not only helps the wound to heal faster by aiding to the growth of new cells, but also decrease discomfort to a certain extent. The requirement for wound dressing is now not only limited to trauma patients or household accident cases, but also includes diabetic geriatrics who commonly suffer from ulcerative complications.
Rise in global elderly population that commonly suffers from various skin ulcers complications is leading to increased requirement of advanced wound dressing technologies. Additionally the growing prevalence of chronic diseases and rising healthcare expenditure among the urban and rural populations are fuelling the demand of wound dressings.
Global Wound Dressings delivery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market.
Major players in the wound dressings market include 3M (US), Smith & Nephew plc (UK), Integra LifeSciences Holdings Corporation (US), Mölnlycke Health Care AB (Sweden), ConvaTec Group plc (UK), Coloplast A/S (Denmark), Medline Industries, Inc. (US), Advanced Medical Solutions Group plc (UK), Hollister Incorporated (US), B. Braun Melsungen AG (Germany), DeRoyal Industries, Inc. (US), PAUL HARTMANN AG (Germany), Advancis Medical (UK), Cardinal Health (US), Lohmann& Rauscher International GmbH & Co. KG (Germany), DermaRite Industries, LLC (US), Urgo Medical (France), Shield Line (US), Zeni Medical (US), and Winner Medical Co., Ltd. (China).
3M (US) is the leading player in the global wound dressings market. The company concentrates on organic and inorganic growth strategies to increase its market share, for instance it is emphasizing upon new product developments as well as acquisitions to further upsurge its share in the wound dressings market. 3M is aninnovator in advanced wound care and has been in the market for more than 15 years, which provides it with a competitive advantage in the market. The company is focusing on increasing its customer base and expanding its geographic footprint in unexplore devolving markets.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Global liposomal drug delivery devices market is projected to grow at a CAGR of 10.69% by 2032.
21 June 2022
The global nanotechnology in drug delivery market was valued at US$53.0 billion in 2021 and is projected to grow at a CAGR of 18.7% during the forecast period 2022-2032.
20 June 2022
The global respiratory drug delivery technologies market was valued at US$59.51 billion in 2022 and is projected to grow at a CAGR of 7.31% during the forecast period 2022-2032.
15 June 2022
The global artificial intelligence (AI) in drug discovery market was valued at US$791 million in 2021 and is projected to grow at a CAGR of 30.7% during the forecast period 2022-2032.